We are live on ! Find out more
SGRX icon

Sangrix

3 hedge funds and large institutions have $572K invested in Sangrix in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.27% less ownership

Funds ownership: 2.16% → 0.89% (-1.3%)

40% less funds holding

Funds holding: 5 → 3 (-2)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $318K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SGRX Hedge Fund Activity: Q2 2021 in Review

3 of the 5,771 institutional investors tracked by Wall St. Rank reported a position in Sangrix (SGRX) for Q2 2021, worth a combined $572K — down 15% from $673K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of SGRX and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Squarepoint, exiting entirely with an estimated $148K sold.

  • 3 institutional investors held Sangrix (SGRX) as of Q2 2021, down from 5 in Q1 2021.
  • Funds reported $572K of Sangrix stock for Q2 2021, down 15% quarter-over-quarter.
  • 0 funds opened new Sangrix positions in Q2 2021 and 2 closed out, a net change of -2 holders.
  • The largest Sangrix seller in Q2 2021 was Squarepoint, an estimated $148K sold.

Based on aggregated 13F filings for Q2 2021.